The company has significantly boosted its development of a novel solution for amyloid heart disease, leveraging the compound. Preliminary clinical data reveals promising outcomes for those diagnosed by the debilitating https://bridgebio205586.dm-blog.com/42476863/company-advances-cardiac-amyloidosis-treatment-with-the-drug